• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 filed by Enhabit Inc.

    6/26/25 5:25:21 PM ET
    $EHAB
    Medical/Nursing Services
    Health Care
    Get the next $EHAB alert in real time by email
    S-8 1 enhabits-8x06262025.htm S-8 Document

    As filed with the Securities and Exchange Commission on June 26, 2025
    Registration No. 333-
    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    FORM S-8
    REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933
    Enhabit, Inc.
    (Exact name of registrant as specified in its charter)
    Delaware
    (State or other jurisdiction
    of incorporation or organization)
    47-2409192
    (I.R.S. Employer
    Identification No.)
    6688 N. Central Expressway, Suite 1300
    Dallas, Texas
    (Address of Principal Executive Offices)
    75206
    (Zip Code)
    Enhabit, Inc. 2025 Equity and Incentive Compensation Plan
    (Full title of the plan)

    Dylan C. Black
    General Counsel
    Enhabit, Inc.
    6688 N. Central Expressway, Suite 1300
    Dallas, Texas 75206
    (Name and address of agent for service)
    (214) 239-6500
    (Telephone number, including area code, of agent for service)
    With a copy to:
    Ferrell M. Keel
    Jones Day
    2727 North Harwood Street, Suite 500
    Dallas, Texas 75201
    (214) 220-3939
    Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

    Large accelerated filer☐
    Accelerated filer
    ☒
    Non-accelerated filer☐
    Smaller reporting company
    ☐
    Emerging growth company
    ☐
    If an emerging growth company, indicate by check mark if the Registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐



    EXPLANATORY NOTE
    This registration statement on Form S-8 (this “Registration Statement”) is being filed by Enhabit, Inc. (the “Registrant”) to register 3,289,042 shares of common stock, par value $0.01 per share (“Common Stock”) that may be delivered to participants under the Enhabit, Inc. 2025 Equity and Incentive Compensation Plan (the “Plan”). The Plan covered by this Registration Statement was approved by the Registrant’s stockholders at its 2025 Annual Meeting of Stockholders held on June 26, 2025.



    PART I
    INFORMATION REQUIRED IN THE SECTION 10(a) PROSPECTUS
    Item 1. Plan Information.
    The document(s) containing the information specified in Part I of the Registration Statement will be sent or given to the participants as specified by Rule 428(b) of the Securities Act of 1933, as amended (the “Securities Act”). Such documents are not required to be, and are not, filed with the Securities and Exchange Commission (the “Commission”), either as part of this Registration Statement or as prospectuses or prospectus supplements pursuant to Rule 424 under the Securities Act. These documents, and the documents incorporated by reference herein pursuant to Item 3 of Part II hereof, taken together, constitute a prospectus that meets the requirements of Section 10(a) of the Securities Act.
    Item 2. Registrant Information and Employee Plan Annual Information.
    The written statement required by Item 2 of Part I is included in documents that will be delivered to participants in the plans covered by this Registration Statement pursuant to Rule 428(b) of the Securities Act.
    PART II
    INFORMATION REQUIRED IN THE REGISTRATION STATEMENT
    Item 3. Incorporation of Documents by Reference.
    The following documents, which have been filed by the Registrant with the Commission, are incorporated in this Registration Statement by reference:
    1.The Registrant’s Annual Report on Form 10-K for the year ended December 31, 2024, filed with the Commission on March 6, 2025, as amended by the Amendment No. 1 on Form 10-K/A, filed with the Commission on April 29, 2025 (as amended, the “Annual Report”);
    2.The Registrant’s Quarterly Report on Form 10-Q for the quarterly period ended March 31, 2025, as filed with the Commission on May 8, 2025; and
    3.The description of the Registrant’s Common Stock contained in the Information Statement filed as Exhibit 99.1 to Amendment No. 2 to the Registrant’s Registration Statement on Form 10 filed with the Commission on June 14, 2022, pursuant to Section 12(b) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), including any amendments or reports filed for the purpose of updating such description, including the description of the Common Stock contained in Exhibit 4.1 to the Annual Report.
    All reports and other documents subsequently filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act (other than Current Reports on Form 8-K furnished pursuant to Item 2.02 or Item 7.01 of Form 8-K, including any exhibits included with such information that are related to such items) after the date of this Registration Statement, but prior to the filing of a post-effective amendment which indicates that all securities offered hereby have been sold or which deregisters all securities then remaining unsold, shall be deemed to be incorporated by reference herein and to be a part hereof from the date of filing of such documents; provided, however, that documents or information deemed to have been furnished and not filed in accordance with the rules of the Commission shall not be deemed incorporated by reference into this Registration Statement.
    Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any other subsequently filed document which also is or is deemed to be incorporated by reference herein modifies or supersedes such statement. Any statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.
    Item 4. Description of Securities.
    Not applicable.
    Item 5. Interests of Named Experts and Counsel.
    Not applicable.



    Item 6. Indemnification of Directors and Officers.
    Section 145(a) of the General Corporation Law of the State of Delaware (the “DGCL”) provides, in general, that a corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action, suit or proceeding, whether civil, criminal, administrative or investigative (other than an action by or in the right of the corporation), because he or she is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement actually and reasonably incurred by the person in connection with such action, suit or proceeding, if he or she acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the corporation and, with respect to any criminal action or proceeding, had no reasonable cause to believe his or her conduct was unlawful.
    Section 145(b) of the DGCL provides, in general, that a corporation may indemnify any person who was or is a party or is threatened to be made a party to any threatened, pending or completed action or suit by or in the right of the corporation to procure a judgment in its favor because the person is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise, against expenses (including attorneys’ fees) actually and reasonably incurred by the person in connection with the defense or settlement of such action or suit if he or she acted in good faith and in a manner he or she reasonably believed to be in or not opposed to the best interests of the corporation, except that no indemnification shall be made with respect to any claim, issue or matter as to which he or she shall have been adjudged to be liable to the corporation unless and only to the extent that the Court of Chancery or other adjudicating court determines that, despite the adjudication of liability but in view of all of the circumstances of the case, he or she is fairly and reasonably entitled to indemnity for such expenses that the Court of Chancery or other adjudicating court shall deem proper.
    Section 145(g) of the DGCL provides, in general, that a corporation may purchase and maintain insurance on behalf of any person who is or was a director, officer, employee or agent of the corporation, or is or was serving at the request of the corporation as a director, officer, employee or agent of another corporation, partnership, joint venture, trust or other enterprise against any liability asserted against such person and incurred by such person in any such capacity, or arising out of his or her status as such, whether or not the corporation would have the power to indemnify the person against such liability under Section 145 of the DGCL.
    If the DGCL is amended to authorize corporate action further eliminating or limiting the personal liability of directors, then the liability of the directors will be eliminated or limited to the fullest extent permitted by the DGCL, as so amended.
    Delaware law, Article Nine of the Registrant’s Amended and Restated Certificate of Incorporation and Article VI of the Registrant’s Amended and Restated Bylaws provide that the Registrant will, in certain situations, indemnify its directors and officers and may indemnify other employees and other agents, to the fullest extent permitted by law. Any indemnified person is also entitled, subject to certain limitations, to advancement, direct payment, or reimbursement of reasonable expenses (including attorneys’ fees and disbursements) in advance of the final disposition of the proceeding.
    The Registrant also maintains a directors’ and officers’ insurance policy pursuant to which its directors and officers are insured against liability for actions taken in their capacities as directors and officers. The Registrant believes these provisions in its Amended and Restated Certificate of Incorporation and Amended and Restated Bylaws are necessary to attract and retain qualified persons as directors and officers.
    Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers, or control persons, in the opinion of the Commission, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.
    Item 7. Exemption from Registration Claimed.
    Not applicable.



    Item 8. Exhibits.
    Exhibit
    Number
    Exhibit Description
    4.1
    Amended and Restated Certificate of Incorporation of Enhabit, Inc. (incorporated by reference to Exhibit 3.1.2 to Enhabit, Inc.’s Current Report on Form 8-K filed with the Commission on July 5, 2022).
    4.2
    Amended and Restated Bylaws of Enhabit, Inc. (incorporated by reference to Exhibit 3.2 to Enhabit, Inc.’s Quarterly Report on Form 10-Q filed with the Commission on November 14, 2022).
    4.3†*
    Enhabit, Inc. 2025 Equity and Incentive Compensation Plan
    5.1†
    Opinion of Jones Day.
    23.1†
    Consent of PricewaterhouseCoopers LLP.
    23.2†
    Consent of Jones Day (included in Exhibit 5.1).
    24.1†
    Power of Attorney (included on the signature page hereto).
    107†
    Filing Fee Table.
    † Submitted electronically herewith.
    * Indicates management contracts or compensatory plans or arrangements filed pursuant to Item 601(b)(10)(iii) of Regulation S-K.
    Item 9. Undertakings.
    (a)The undersigned Registrant hereby undertakes:
    (1)To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:
    (i)To include any prospectus required by Section 10(a)(3) of the Securities Act;
    (ii)To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Filing Fee Tables” or “Calculation of Registration Fee” table, as applicable, in the effective Registration Statement; and
    (iii)To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement;

    Provided, however, that paragraphs (a)(1)(i) and (a)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in the Registration Statement.
    (2)That, for the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
    (3)To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.
    (b)The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the Registration Statement shall be deemed to be a new registration statement relating to the



    securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.
    (c)Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.
    SIGNATURES
    Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Dallas, State of Texas, on June 26, 2025.
    ENHABIT, INC.
    By:/s/ Ryan T. Solomon
    Ryan T. Solomon
    Chief Financial Officer



    POWER OF ATTORNEY
    KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Ryan T. Solomon and Dylan C. Black, and each of them, his or her true and lawful attorneys-in-fact and agents with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any or all amendments (including post-effective amendments) to this Registration Statement and any and all related registration statements pursuant to Rule 462(b) of the Securities Act, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Commission, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.
    Pursuant to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.
    NameTitleDate
    /s/ Barbara A. JacobsmeyerPresident and Chief Executive Officer and Director
    (Principal Executive Officer)
    June 26, 2025
    Barbara A. Jacobsmeyer
    /s/ Ryan T. SolomonChief Financial Officer (Principal Financial Officer)
    June 26, 2025
    Ryan T. Solomon
    /s/ Collin S. McQuiddySenior Vice President and Chief Accounting Officer (Principal Accounting Officer)
    June 26, 2025
    Collin S. McQuiddy
    /s/ Jeffrey W. BoltonDirector, Chairperson
    June 26, 2025
    Jeffrey W. Bolton
    /s/ Tina L. Brown-StevensonDirector
    June 26, 2025
    Tina L. Brown-Stevenson
    /s/ Charles M. ElsonDirector
    June 26, 2025
    Charles M. Elson
    /s/ Erin P. HoeflingerDirector
    June 26, 2025
    Erin P. Hoeflinger
    /s/ Stuart M. McGuiganDirector
    June 26, 2025
    Stuart M. McGuigan
    /s/ Mark W. OhlendorfDirector
    June 26, 2025
    Mark W. Ohlendorf
    /s/ Gregory S. RushDirector
    June 26, 2025
    Gregory S. Rush
    /s/ Barry P. SchochetDirector
    June 26, 2025
    Barry P. Schochet


    Get the next $EHAB alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $EHAB

    DatePrice TargetRatingAnalyst
    12/9/2024$8.25 → $9.50Hold → Buy
    Jefferies
    5/14/2024$8.50Underperform → Market Perform
    Leerink Partners
    5/9/2024$14.00 → $8.75Buy → Hold
    Jefferies
    3/7/2024$9.50Sell → Neutral
    UBS
    12/12/2023$12.00Market Perform
    TD Cowen
    6/20/2023$10.00Underperform
    SVB Securities
    3/16/2023$15.00Neutral
    Goldman
    12/13/2022$18.00Market Perform
    CJS Securities
    More analyst ratings

    $EHAB
    SEC Filings

    See more
    • Enhabit Inc. filed SEC Form 8-K: Leadership Update, Submission of Matters to a Vote of Security Holders, Financial Statements and Exhibits

      8-K - Enhabit, Inc. (0001803737) (Filer)

      6/26/25 5:28:32 PM ET
      $EHAB
      Medical/Nursing Services
      Health Care
    • SEC Form S-8 filed by Enhabit Inc.

      S-8 - Enhabit, Inc. (0001803737) (Filer)

      6/26/25 5:25:21 PM ET
      $EHAB
      Medical/Nursing Services
      Health Care
    • Enhabit Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Enhabit, Inc. (0001803737) (Filer)

      6/9/25 4:21:29 PM ET
      $EHAB
      Medical/Nursing Services
      Health Care

    $EHAB
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • New insider Rodgers Stephan claimed ownership of 15,773 shares (SEC Form 3)

      3 - Enhabit, Inc. (0001803737) (Issuer)

      7/2/25 5:27:16 PM ET
      $EHAB
      Medical/Nursing Services
      Health Care
    • Chief Human Resources Officer Marion Tanya Renee covered exercise/tax liability with 1,983 shares, decreasing direct ownership by 3% to 57,651 units (SEC Form 4)

      4 - Enhabit, Inc. (0001803737) (Issuer)

      7/2/25 5:22:37 PM ET
      $EHAB
      Medical/Nursing Services
      Health Care
    • EVP of Home Health Operations Jolley Julie Diane covered exercise/tax liability with 3,032 shares, decreasing direct ownership by 3% to 89,227 units (SEC Form 4)

      4 - Enhabit, Inc. (0001803737) (Issuer)

      7/2/25 5:21:20 PM ET
      $EHAB
      Medical/Nursing Services
      Health Care

    $EHAB
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Enhabit Inc. upgraded by Jefferies with a new price target

      Jefferies upgraded Enhabit Inc. from Hold to Buy and set a new price target of $9.50 from $8.25 previously

      12/9/24 7:37:08 AM ET
      $EHAB
      Medical/Nursing Services
      Health Care
    • Enhabit Inc. upgraded by Leerink Partners with a new price target

      Leerink Partners upgraded Enhabit Inc. from Underperform to Market Perform and set a new price target of $8.50

      5/14/24 7:59:14 AM ET
      $EHAB
      Medical/Nursing Services
      Health Care
    • Enhabit Inc. downgraded by Jefferies with a new price target

      Jefferies downgraded Enhabit Inc. from Buy to Hold and set a new price target of $8.75 from $14.00 previously

      5/9/24 6:24:32 AM ET
      $EHAB
      Medical/Nursing Services
      Health Care

    $EHAB
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Enhabit Announces Participation in Goldman Sachs 46th Annual Global Healthcare Conference

      Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced its participation in the Goldman Sachs 46th Annual Global Healthcare Conference. Enhabit's President and CEO Barb Jacobsmeyer and Chief Financial Officer Ryan Solomon will participate in a fireside chat on Tuesday, June 10, at 10 a.m. EDT. The fireside chat will be webcast live and available for replay at https://investors.ehab.com. About Enhabit Home Health & Hospice Enhabit Home Health & Hospice (Enhabit, Inc.) is a leading national home health and hospice provider working to expand what's possible for patient care in the home. Enhabit's team of clinicians supports patients and their familie

      5/20/25 4:10:00 PM ET
      $EHAB
      Medical/Nursing Services
      Health Care
    • Enhabit Reports First Quarter 2025 Financial Results

      Company to host a conference call tomorrow, May 8, 2025, at 10 a.m. EDT Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the first quarter ended March 31, 2025. "Enhabit's first quarter 2025 results are a product of steadfast execution of our strategies," said Barb Jacobsmeyer, president and CEO of Enhabit. "Home health census grew 3.7% sequentially and hospice census grew 12.3% year over year. The combination of strong growth, improved profitability and continued balance sheet improvements resulted in a leverage ratio now below 4.5 times. This enables us to formally exit the covenant relief period restrictions in our

      5/7/25 4:15:00 PM ET
      $EHAB
      Medical/Nursing Services
      Health Care
    • Enhabit Home Health & Hospice Announces Date of 2025 First Quarter Earnings Call

      Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it will report its results for the first quarter ended March 31, 2025, on May 7, 2025, and host a webcast and conference call on May 8, 2025. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. May 8, 2025 10 a.m. EDT Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Webcast link: https://events.q4inc.com/attendee/885393432 A link to the webcast of the conference call and online replay can be found on Enhabit's investor website. About Enhabit Home Health & Hospice Enhabit Home Hea

      4/17/25 4:12:00 PM ET
      $EHAB
      Medical/Nursing Services
      Health Care

    $EHAB
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by Enhabit Inc.

      SC 13G - Enhabit, Inc. (0001803737) (Subject)

      11/14/24 9:12:39 PM ET
      $EHAB
      Medical/Nursing Services
      Health Care
    • Amendment: SEC Form SC 13G/A filed by Enhabit Inc.

      SC 13G/A - Enhabit, Inc. (0001803737) (Subject)

      10/4/24 1:56:05 PM ET
      $EHAB
      Medical/Nursing Services
      Health Care
    • SEC Form SC 13G/A filed by Enhabit Inc. (Amendment)

      SC 13G/A - Enhabit, Inc. (0001803737) (Subject)

      2/13/24 5:04:31 PM ET
      $EHAB
      Medical/Nursing Services
      Health Care

    $EHAB
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Bolton Jeffrey bought $34,760 worth of shares (4,000 units at $8.69), increasing direct ownership by 4% to 98,144 units (SEC Form 4)

      4 - Enhabit, Inc. (0001803737) (Issuer)

      12/12/24 5:01:19 PM ET
      $EHAB
      Medical/Nursing Services
      Health Care
    • Director Mcguigan Stuart M bought $132,150 worth of shares (15,000 units at $8.81), increasing direct ownership by 47% to 46,810 units (SEC Form 4)

      4 - Enhabit, Inc. (0001803737) (Issuer)

      12/11/24 5:56:33 PM ET
      $EHAB
      Medical/Nursing Services
      Health Care
    • Director Bolton Jeffrey bought $77,177 worth of shares (10,000 units at $7.72), increasing direct ownership by 12% to 94,144 units (SEC Form 4)

      4 - Enhabit, Inc. (0001803737) (Issuer)

      11/12/24 5:14:12 PM ET
      $EHAB
      Medical/Nursing Services
      Health Care

    $EHAB
    Leadership Updates

    Live Leadership Updates

    See more
    • Delaware Court of Chancery Awards Damages and Other Relief to Encompass Health and Enhabit for Misconduct by April Anthony, Other Former Officers, and Private Equity Firms Vistria Group and Nautic Partners

      On Monday, Encompass Health and Enhabit won their lawsuit in the Delaware Court of Chancery related to breaches of fiduciary duty by April Anthony, Luke James, and Chris Walker while they served as the senior officers at Encompass Health's former home health and hospice division, which is now Enhabit. The Court awarded judgment against private equity firms Vistria Group and Nautic Partners and the home health and hospice business now known as VitalCaring Group for aiding and abetting "the egregious breaches of the duty of loyalty" by Anthony, James, and Walker. The case was the subject of a 7-day trial in December 2023. After considering "the damning record presented at trial," the Court

      12/4/24 8:30:00 AM ET
      $EHAB
      $EHC
      Medical/Nursing Services
      Health Care
      Hospital/Nursing Management
    • Enhabit Home Health & Hospice Appoints Ryan Solomon as Chief Financial Officer

      Seasoned Industry Executive Brings Significant Financial Operations Expertise and Track Record of Driving Growth and Value Creation Enhabit, Inc. (NYSE:EHAB), ("Enhabit"), a leading home health and hospice provider, today announced the appointment of Ryan Solomon as its next chief financial officer (CFO), effective Dec. 9, 2024. Mr. Solomon's appointment follows the previously announced transition of Crissy Carlisle, CFO. Mr. Solomon brings to Enhabit over 20 years of corporate strategy and finance experience, including eight years as CFO in the home health and hospice space and other industries. Mr. Solomon previously served as CFO of AccentCare, where he was responsible for financial pl

      11/7/24 7:30:00 AM ET
      $EHAB
      Medical/Nursing Services
      Health Care
    • American Water Appoints New Independent Member to the Board of Directors

      American Water Works Company, Inc. (NYSE:AWK) announced today that Stuart M. McGuigan has been appointed as an independent member of the company's board of directors, effective Oct. 29, 2024. "American Water is pleased to have Stuart join our board of directors," said Karl Kurz, Board Chair of American Water. "Stuart has more than 38 years of extensive experience in information technology and management including serving as the Chief Information Officer for national and global public companies, as well as a government agency. He will further strengthen our board, and we look forward to working with him." "We are honored to have Stuart become part of American Water's board," said M. Susan

      10/30/24 4:46:00 PM ET
      $AWK
      $EHAB
      Water Supply
      Utilities
      Medical/Nursing Services
      Health Care

    $EHAB
    Financials

    Live finance-specific insights

    See more
    • Enhabit Reports First Quarter 2025 Financial Results

      Company to host a conference call tomorrow, May 8, 2025, at 10 a.m. EDT Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the first quarter ended March 31, 2025. "Enhabit's first quarter 2025 results are a product of steadfast execution of our strategies," said Barb Jacobsmeyer, president and CEO of Enhabit. "Home health census grew 3.7% sequentially and hospice census grew 12.3% year over year. The combination of strong growth, improved profitability and continued balance sheet improvements resulted in a leverage ratio now below 4.5 times. This enables us to formally exit the covenant relief period restrictions in our

      5/7/25 4:15:00 PM ET
      $EHAB
      Medical/Nursing Services
      Health Care
    • Enhabit Home Health & Hospice Announces Date of 2025 First Quarter Earnings Call

      Enhabit, Inc. (NYSE:EHAB), a leading national home health and hospice provider, today announced it will report its results for the first quarter ended March 31, 2025, on May 7, 2025, and host a webcast and conference call on May 8, 2025. Individuals who would like to participate in the conference call webcast should join 15 minutes before the scheduled start time. May 8, 2025 10 a.m. EDT Toll-free: 888-660-6150 International: 929-203-0843 Conference ID: 5248158 Webcast link: https://events.q4inc.com/attendee/885393432 A link to the webcast of the conference call and online replay can be found on Enhabit's investor website. About Enhabit Home Health & Hospice Enhabit Home Hea

      4/17/25 4:12:00 PM ET
      $EHAB
      Medical/Nursing Services
      Health Care
    • Enhabit Reports Fourth Quarter Results and Issues Full-Year 2025 Guidance

      Company to host a conference call tomorrow, March 6, 2025, at 10 a.m. EST Enhabit, Inc. (NYSE:EHAB), a leading home health and hospice care provider, today reported its results of operations for the fourth quarter ended Dec. 31, 2024. "Enhabit is exiting 2024 having executed specific strategies that set us up for long-term growth in both our home health and hospice segments," said Barb Jacobsmeyer, president and chief executive officer of Enhabit. "In our home health segment, fourth quarter Medicare census continued to stabilize, and with the renegotiation of a large national contract complete, we will be well positioned as a full-service provider to our referral sources. The hospice segm

      3/5/25 4:16:00 PM ET
      $EHAB
      Medical/Nursing Services
      Health Care